The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level

Oncogene
I Ben SahraF Bost

Abstract

Metformin is a widely used antidiabetic agent, which regulates glucose homeostasis through inhibition of liver glucose production and an increase in muscle glucose uptake. Recent studies suggest that metformin may reduce the risk of cancer, but its mode of action in cancer remains not elucidated. We investigated the effect of metformin on human prostate cancer cell proliferation in vitro and in vivo. Metformin inhibited the proliferation of DU145, PC-3 and LNCaP cancer cells with a 50% decrease of cell viability and had a modest effect on normal prostate epithelial cell line P69. Metformin did not induce apoptosis but blocked cell cycle in G(0)/G(1). This blockade was accompanied by a strong decrease of cyclin D1 protein level, pRb phosphorylation and an increase in p27(kip) protein expression. Metformin activated the AMP kinase pathway, a fuel sensor signaling pathway. However, inhibition of the AMPK pathway using siRNA against the two catalytic subunits of AMPK did not prevent the antiproliferative effect of metformin in prostate cancer cells. Importantly, oral and intraperitoneal treatment with metformin led to a 50 and 35% reduction of tumor growth, respectively, in mice bearing xenografts of LNCaP. Similar, to the in vitro...Continue Reading

References

May 15, 1995·Genes & Development·C J Sherr, J M Roberts
Mar 1, 1994·Molecular and Cellular Biology·H MatsushimeJ Y Kato
Feb 7, 1997·Cell·T Hunter
Mar 27, 2001·Gastroenterology·M B SchneiderP M Pour
Sep 25, 2001·Lancet·G MarchesiniN Melchionda
Oct 17, 2001·The Journal of Clinical Investigation·G ZhouD E Moller
Jul 17, 2003·Acta Physiologica Scandinavica·N B RudermanA K Saha
Oct 25, 2003·BMJ : British Medical Journal·Jonathan M LordRobert J Norman
Jan 27, 2004·The Prostate·Samuel R Denmeade, John T Isaacs
Apr 26, 2005·BMJ : British Medical Journal·Josie M M EvansAndrew D Morris
Dec 27, 2005·Biochemical and Biophysical Research Communications·Yossi DagonElliot M Berry
Jan 31, 2006·Diabetes·Myriam AouadiFrédéric Bost
May 11, 2006·The Journal of Clinical Endocrinology and Metabolism·Lourdes IbáñezFrancis de Zegher
Oct 26, 2006·Cancer Research·Mahvash ZakikhaniMichael Pollak
Jun 16, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Yan ZhangChuan-ju Liu

❮ Previous
Next ❯

Citations

Jul 15, 2009·Diabetologia·U Smith, E A M Gale
Mar 6, 2010·Breast Cancer Research and Treatment·Kathryn N PhoenixKevin P Claffey
Aug 5, 2009·Cancer Causes & Control : CCC·Jonathan L Wright, Janet L Stanford
Apr 25, 2012·Cancer Causes & Control : CCC·Adedayo A OnitiloSuhail A Doi
Jun 23, 2011·Frontiers of Medicine·Yonghua Yang
Feb 9, 2011·Medical Oncology·Taxiarchis V Kourelis, Robert D Siegel
Jun 19, 2013·Trends in Endocrinology and Metabolism : TEM·Brendan J QuinnPhillip A Dennis
Nov 26, 2008·Nature Reviews. Cancer·Michael Pollak
Nov 28, 2013·Nature Reviews. Clinical Oncology·Ian M ThompsonMichael J Wargovich
May 23, 2012·Prostate Cancer and Prostatic Diseases·A J ColquhounV Venkateswaran
Nov 26, 2010·Proceedings of the National Academy of Sciences of the United States of America·Eva KicksteinSusann Schweiger
Mar 19, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·X-X HeS-C J Yeung
Mar 23, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A ClementsH Gurney
Oct 17, 2013·Carcinogenesis·Tunde AkinyekeXin Li
Jul 16, 2013·Journal of the National Cancer Institute·David MargelNeil Fleshner
Nov 30, 2011·Current Opinion in Oncology·Frédéric BostJean-François Tanti
Jun 23, 2012·Pharmacogenetics and Genomics·Li GongTeri E Klein
Jun 16, 2012·Journal of Oncology·Ramandeep RattanAdnan Munkarah
Apr 16, 2009·Cancer Research·Hyun Goo WooSnorri S Thorgeirsson
Mar 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ana M Gonzalez-Angulo, Funda Meric-Bernstam
Apr 29, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Giorgia ZadraMassimo Loda
Apr 3, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Navid SadeghiDonghui Li
Mar 23, 2011·Molecular Cancer Research : MCR·Yongxian Zhuang, W Keith Miskimins
Sep 3, 2010·Cancer Prevention Research·Regan M MemmottPhillip A Dennis
Apr 3, 2012·Cancer Prevention Research·Kavita BhallaGeoffrey D Girnun
May 12, 2012·Cancer Discovery·Matthew J MartinRichard Marais
Jun 1, 2010·Therapeutic Advances in Endocrinology and Metabolism·Hany Lashen
Apr 8, 2011·BMC Medicine·Ryan J O DowlingVuk Stambolic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.